Back to search

Innervate Therapeutics Ltd

11922783

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

ST BRANDON'S HOUSE, BRISTOL, BS1 5QT
Incorporated 03/04/2019

Compliance

Last accounts

30/04/2025

total exemption full

Next accounts due

31/01/2027

On track

Confirmation statement

Last: 06/11/2025

Due 20/11/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Steven Streatfield Gill

director · Since 03/04/2019

DIRECTOR

BRITISH · UNITED KINGDOM · Age 69

Also on 1 other board

Ms Theresa Margaret Bruce

director · Since 27/10/2020

DIRECTOR

BRITISH · SCOTLAND · Age 62

Also on 1 other board

Mrs Sharon Lilley Kane

director · Since 05/08/2021

DIRECTOR

BRITISH · SCOTLAND · Age 53

Also on 6 other boards

Persons with Significant Control

Prof Steven Streatfield Gill

50–75% shares
50–75% votes

British · England · Age 69

St Brandon's House, 29 Great George Street, Bristol, BS1 5QT

Notified 30/10/2020

Former PSCs

Xced Llp

Ceased 30/10/2020

CompanyRankvs 2334+ SIC 72110 peers
38

Financial strength7th percentile among SIC peers · 2/25
Employees82th percentile among SIC peers · 12/15
LiquidityCurrent ratio 0.13× · 2/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
2334Innervate Therapeutics Ltd
38
How is this score calculated?
Financial strength2/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

-£207k

Balance sheet strength

Cash

£8k

Cash in the bank

Net Current Assets

-£86k

Working capital

Current Assets

£13k

Current Liabilities

£99k

Debtors

£4k

4avg. employees

Balance Sheet

Intangible assets£335k
Assets less current liabilities£248k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.13-£68k
20241.25-£39k
20230.81-£11k
20220.93-£43k
20210.49-£7k
20200.45—

Derived from filed accounts. Not audited figures.